About Avience Biomedicals
The shares listed at ₹395.20, a 90.00% move from the issue price. Avience Biomedicals is a SME IPO with an issue size of ₹30.24 crore, proposed for listing on NSE SME. The offer opens on 18th Jun 2026 and closes on 22nd Jun 2026. The issue structure includes a fresh issue of ₹28.53 crore. The current listing schedule points to 25th Jun 2026.
Company Contact
Address—
Phone—
Websitehttps://www.ipomatrix.com/